期刊文献+

CHO细胞株开发技术策略探讨 被引量:3

Strategy Discussion for CHO Cell Line Development
下载PDF
导出
摘要 主要介绍了单克隆抗体药物工业生产中宿主细胞选择、表达载体构建、转染方法、筛选技术、细胞培养工艺技术方法以及最后选定细胞株的标准等,结合单抗药物CHO细胞株开发和培养工艺的经验,对当前我国单抗CHO细胞株开发技术策略进行了探讨。 Several strategies for industrial production of monoclonal antibody drug were introduced in this paper, including host cell selection, construction of expression vector, transfection method, screening techniques, cell culture technology as well as the standard method of final cell lines selection. On the basis of the progress of monoclonal antibody drug CHO cell line development and cell culture process, current strategy for the development of CHO cell lines in monoclonal antibody technology were also discussed.
出处 《生物技术进展》 2014年第6期394-399,共6页 Current Biotechnology
基金 上海市科学技术委员会"科技型中小企业技术创新资金"项目(1402H195100)资助
关键词 单克隆抗体 CHO细胞 细胞株开发 培养工艺 monoclonal antibody CHO cell cell line development cell culture process
  • 相关文献

参考文献8

  • 1Pei‐QiLiu,Edmond M.Chan,Gregory J.Cost,LinZhang,JianbinWang,Jeffrey C.Miller,Dmitry Y.Guschin,AndreasReik,Michael C.Holmes,John E.Mott,Trevor N.Collingwood,Philip D.Gregory.Generation of a triple‐gene knockout mammalian cell line using engineered zinc‐finger nucleases[J].Biotechnol Bioeng.2010(1) 被引量:1
  • 2李浩强,蔡洁行,张玉彬.治疗性抗体高表达CHO细胞株构建策略[J].中国医药生物技术,2013,8(3):220-224. 被引量:5
  • 3Jee Yon Kim,Yeon-Gu Kim,Gyun Min Lee.CHO cells in biotechnology for production of recombinant proteins: current state and further potential[J].Applied Microbiology and Biotechnology.2012(3) 被引量:1
  • 4Say Kong Ng,Daniel I.C. Wang,Miranda G.S. Yap.Application of destabilizing sequences on selection marker for improved recombinant protein productivity in CHO-DG44[J].Metabolic Engineering.2007(3) 被引量:1
  • 5M. Butler,A. Meneses-Acosta.Recent advances in technology supporting biopharmaceutical production from mammalian cells[J].Applied Microbiology and Biotechnology.2012(4) 被引量:1
  • 6Ashok D. Bandaranayake,Steven C. Almo.Recent advances in mammalian protein production[J].FEBS Letters.2013 被引量:1
  • 7刘彦君,赵阳,王征.我国抗体药物产业化发展的策略探讨[J].中国生物工程杂志,2006,26(10):93-97. 被引量:1
  • 8陈飞..DHFR-CHO细胞无血清培养基及其关键组份的研究和应用[D].华东理工大学,2012:

二级参考文献52

  • 1赵阳,王征,吴芳,陆蓓,史文磊,谭靖伟,马文骏,李纲,陆敏,翁洁,吴劲松,王罗春,刘彦君.营养补偿和代谢控制提高细胞蛋白表达的研究[J].中国生物工程杂志,2006,26(4):12-19. 被引量:1
  • 2Chadd H E,Chamow S M.Therapeutic antibody expression technology.Curr Opin Biotechnol,2001,12(2):188 ~ 194 被引量:1
  • 3Brekke O H,Sandlie I.Therapeutic antibodies for human diseases at the dawn of the twenty-first century.Nat Rev Drug Discov,2003,2:52 ~ 62 被引量:1
  • 4Pavlou A K,Belsey M J.The therapeutic antibodies market to 2008.Eur J Pharm Biopharm,2005,59(3):389 ~396 被引量:1
  • 5Sabine L.Can China bring its own pipeline to the market.Nature Biotechnology,2004,22:1497 ~ 1499 被引量:1
  • 6陈志南,邢金良.中国生物技术发展产业报告.北京:化学工业出版社,2004.107~117 被引量:1
  • 7Aldridge S.Biomanufacturing faces new sets of challenges.Genetic Engineering News,2004,24(14):1 被引量:1
  • 8Pavlou A K.Marketspace:The immunotherapies markets,2003-2008.J Commer Biotechnol,2004,10:273 ~278 被引量:1
  • 9Butler M.Animal cell cultures:recent achievements and perspectives in the production of biopharmaceuticals.Appl Microbiol Biotechnol,2005,68:283 ~291 被引量:1
  • 10Datamonitor.Monoclonal antibody therapies:evolving into a $30 billion market.London:Datamonitor Press,2005.103 ~155 被引量:1

共引文献4

同被引文献9

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部